With economic prosperity, political stability and significant growth prospects, Canada has much to admire. However, Canadians still lack universal drug coverage and Canadian health innovation has lagged behind that of the world leaders in this area.

This report explores how these discrepancies are being remedied; including state R&D investment initiatives, increased inter-stakeholder dialogue, and the new strategies of MNCs in Canada. Also featured are the movers and shakers among Canada’s broad spectrum of local companies whose work is helping the nation regain its place at the top table of global healthcare and life sciences.